Literature DB >> 8032233

The efficacy of traditional Chinese herbal therapy in atopic eczema.

Y Latchman1, B Whittle, M Rustin, D J Atherton, J Brostoff.   

Abstract

A traditional Chinese herbal therapy (Zemaphyte) for the treatment of atopic eczema (AE) is currently being assessed. This review attempts to highlight its success in patients who are recalcitrant to Western forms of treatment and the rationale behind its use. The herbal preparation is a mixture of 10 herbs with some known pharmacological agents and actions. The concept of such a complex mixture in clinical treatment is anathema to Western medicine but acceptable in traditional Chinese medicine. As this formation has been shown to be effective in two double-blind crossover trials, investigative work on components from the mixture must be established in order to find the active constituent(s) and describe their mode of action. This research will also lead to a greater understanding of the complex immunopathology of AE.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8032233     DOI: 10.1159/000236669

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  3 in total

1.  The treatment of eczema with Chinese herbs: a systematic review of randomized clinical trials.

Authors:  N C Armstrong; E Ernst
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

2.  Efficacy and Safety of a Traditional Herbal Medicine, Hochu-ekki-to in the Long-term Management of Kikyo (Delicate Constitution) Patients with Atopic Dermatitis: A 6-month, Multicenter, Double-blind, Randomized, Placebo-controlled Study.

Authors:  Hiromi Kobayashi; Masamitsu Ishii; Satoshi Takeuchi; Yoichi Tanaka; Takahiro Shintani; Atsushi Yamatodani; Tadashi Kusunoki; Masutaka Furue
Journal:  Evid Based Complement Alternat Med       Date:  2008-01-31       Impact factor: 2.629

3.  An Alternative Approach to Atopic Dermatitis: Part II-Summary of Cases and Discussion.

Authors:  Hiromi Kobayashi; Kuniaki Takahashi; Nobuyuki Mizuno; Haruo Kutsuna; Masamitsu Ishii
Journal:  Evid Based Complement Alternat Med       Date:  2004-09-01       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.